Abstract
Pediatric Cardiac interventions have come a long way from the initial intervention in the 1950's. Balloon angioplasty has been accepted as the procedure of choice in several congenital anomalies. Apart from balloon angioplasties/valvuloplasties, Atrial Septal Defect, Ventricular Septal Defect (muscular) device closure have been FDA approved with adequate world wide clinical experience and long-term follow-up. In addition, newer procedures are under clinical trial for perimembranous VSD device closure in the catheterization lab; per operative closed heart procedure in the operation theatre or as a hybrid procedure. Palliative procedures like flow restriction to lungs with devices to equate with surgical pulmonary artery banding; stenting of the patent ductus arteriosus in duct dependent cyanotic heart disease in the newborn or a combination of these form transcatheter Norwood stage I in the cath lab. Experience and technology will also help make transcatheter Fontan operation possible and that does not seem too far. The emphasis in pediatric cardiac interventions shall always remain that the decision, procedure, and management of their complications is a joint effort of the surgeon and the interventionalist.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
